Biotechnology Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Changing Frugal Eating Habits – How Novo Nordisk/Eli Lilly’s Weight Loss Drugs Reshaping Food Spending – Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025 – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding Pharmacy – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies – Eli Lilly and Co (NYSE:LLY), Amphastar Pharma (NASDAQ:AMPH) Read more
Biotechnology Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge – Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Is Eli Lilly Winning The War On Weight Loss Drugs? Zepbound Overtakes Wegovy In US Prescriptions – Novo Nordisk (NYSE:NVO), Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology US Prescriptions Race For Weight Loss Drugs – Eli Lilly’s Zepbound Overtakes Novo Nordisk’s Wegovy – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Obesity Drugs On Amazon – Eli Lilly Partners With Amazon’s Pharmacy Unit To Deliver Drug Prescriptions, Including Popular Zepbound For Weight Loss – Eli Lilly and Co (NYSE:LLY) Read more
